Results 261 to 270 of about 697,291 (350)

Current global estimates, risk factors, and knowledge gaps for Hepatitis E virus (HEV): A scoping review. [PDF]

PLoS Negl Trop Dis
Ahmed MK, Maroofi H, Blunt M, Labrique A, Kirkwood C, Vannice K, Talaat KR, Lynch J, Kmush BL.   +8 more
europepmc   +1 more source

Prevalência e características clínico epidemiológicas de gestantes com hepatite C atendidas no CAISM - UNICAMP = Prevalence and clinical epidemiological features of hepatitis C infection among pregnant women at CAISM - UNICAMP

, 2015
Mariana Salhab Dall' Aqua Schweller
openalex   +1 more source

A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in Hepatitis B e antigen-negative chronic hepatitis B

, 2018
Pietro Lampertico
openalex   +1 more source

Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

Developmental Dynamics, EarlyView.
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff, Sandra Schrenk, Kara Soroko, Chhiring Sherpa, Ashok Arasu, Damien Reynaud, Elisa Boscolo   +6 more
wiley   +1 more source

Elevated risk of hepatitis E virus infection among sheep smallholders in Xinjiang, China. [PDF]

One Health
Xu WT, Ding YS, Chen YG, Feng YH, Li J, Jin JG, Wei XN, Wu F, Wang XY, Dang XT, Zhang GW, Xiang XY, Li FY, Zhang WB, Wu JY.   +14 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Genetic insights into hepatitis E virus through environmental surveillance in Europe. [PDF]

One Health
Wang H, Patzi-Churqui M, Andius LD, Nyström K, Lagging M.   +4 more
europepmc   +1 more source

Transcriptomic signatures reveal systemic adaptations and immune modulation in response to training and competitive racing in horses

Equine Veterinary Journal, EarlyView.
Abstract Background The molecular mechanisms underlying adaptation to physical exertion and racing stress in horses remain incompletely understood. Peripheral blood transcriptomics offers a minimally invasive method to monitor systemic responses to exercise and identify biomarkers of adaptation or overload. Objectives To evaluate transcriptomic changes
Izabela Dąbrowska, Jowita Grzędzicka‐Agko, Paula Kiełbik, Michał Trela, Olga Witkowska‐Piłaszewicz   +4 more
wiley   +1 more source

High-pressure processing of pork liver reduces the infectivity of the hepatitis E virus. [PDF]

Appl Environ Microbiol
Pellerin M, Martin J-L, Harlet L, Doceul V, Pavio N, Feurer C.   +5 more
europepmc   +1 more source

Forefront of the viral chronic hepatitis treatment. Treatment of the case for which the treatment plans can not be decided.Chronic hepatitis B. 1. Treatment of the e antigen positive case of high virus quantity.

, 2004
Kazuaki Chayama
openalex   +2 more sources